Catheter Ablation for Paroxysmal Atrial Fibrillation

  • Hakan Oral
    From the Division of Cardiology, University of Michigan, Ann Arbor.
  • Christoph Scharf
    From the Division of Cardiology, University of Michigan, Ann Arbor.
  • Aman Chugh
    From the Division of Cardiology, University of Michigan, Ann Arbor.
  • Burr Hall
    From the Division of Cardiology, University of Michigan, Ann Arbor.
  • Peter Cheung
    From the Division of Cardiology, University of Michigan, Ann Arbor.
  • Eric Good
    From the Division of Cardiology, University of Michigan, Ann Arbor.
  • Srikar Veerareddy
    From the Division of Cardiology, University of Michigan, Ann Arbor.
  • Frank Pelosi
    From the Division of Cardiology, University of Michigan, Ann Arbor.
  • Fred Morady
    From the Division of Cardiology, University of Michigan, Ann Arbor.

書誌事項

タイトル別名
  • Segmental Pulmonary Vein Ostial Ablation Versus Left Atrial Ablation
公開日
2003-11-11
DOI
  • 10.1161/01.cir.0000095796.45180.88
公開者
Ovid Technologies (Wolters Kluwer Health)

この論文をさがす

説明

<jats:p> <jats:bold> <jats:italic>Background—</jats:italic> </jats:bold> Segmental ostial catheter ablation (SOCA) to isolate the pulmonary veins (PVs) and left atrial catheter ablation (LACA) to encircle the PVs both may eliminate paroxysmal atrial fibrillation (PAF). The relative efficacy of these 2 techniques has not been directly compared. </jats:p> <jats:p> <jats:bold> <jats:italic>Methods and Results—</jats:italic> </jats:bold> Of 80 consecutive patients with symptomatic PAF (age, 52±10 years), 40 patients underwent PV isolation by SOCA and 40 patients underwent LACA to encircle the PVs. During SOCA, ostial PV potentials recorded with a ring catheter were targeted. LACA was performed by encircling the left- and right-sided PVs 1 to 2 cm from the ostia and was guided by an electroanatomic mapping system; ablation lines also were created in the mitral isthmus and posterior left atrium. The mean procedure and fluoroscopy times were 156±45 and 50±17 minutes for SOCA and 149±33 and 39±12 minutes for LACA, respectively. At 6 months, 67% of patients who underwent SOCA and 88% of patients who underwent LACA were free of symptomatic PAF when not taking antiarrhythmic drug therapy ( <jats:italic>P</jats:italic> =0.02). Among the variables of age, sex, duration and frequency of PAF, ejection fraction, left atrial size, structural heart disease, and the ablation technique, only an increased left atrial size and the SOCA technique were independent predictors of recurrent PAF. The only complication was left atrial flutter in a patient who underwent LACA. </jats:p> <jats:p> <jats:bold> <jats:italic>Conclusions—</jats:italic> </jats:bold> In patients undergoing catheter ablation for PAF, LACA to encircle the PVs is more effective than SOCA. </jats:p>

収録刊行物

  • Circulation

    Circulation 108 (19), 2355-2360, 2003-11-11

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (47)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ